After dividing our patients into a low-grade and a high-grade subgroup, we did not observe significant changes in the proportions of CD47+ tumor cells between these groups, nor in the two different tissue compartments (tumor center, tumor periphery) within the same subgroup. This evidence concerns the gene CD47 and neoplasm.